Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
This study has been completed.
Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Collaborators:
American Cancer Society, Inc.
Avon Foundation
Cancer Treatment Research Foundation
The Commonwealth Fund
Genentech
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00399529
First received: November 13, 2006
Last updated: December 11, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | November 29, 2012 |